Trial NCT03684785

View at ClinicalTrials.gov 
Org. Study IDs: AST-008-102

Last trial update was posted on 2022-04-07

MeSH Interventions

Cemiplimab Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Merkel Cell Carcinoma, Squamous Cell Melanoma Squamous Cell Carcinoma of Head and Neck

Other Conditions

Advanced or Metastatic Cutaneous Squamous Cell Carcinoma Advanced or Metastatic Head and Neck Squamous Cell Carcinoma Advanced or Metastatic Melanoma Advanced or Metastatic Merkel Cell Carcinoma Advanced or Metastatic Solid Tumors

Stopping Reasons

The study was canceled for administrative reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID